Immunogen reported $77.09M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Agios Pharmaceuticals AGIO:US $ 1394.76M 327.05M
Amgen AMGN:US $ 8217M 30M
Arena Pharmaceuticals ARNA:US $ 800.72M 170.36M
Astellas Pharma 4503:JP Y 1417622M 34753M
AstraZeneca AZN:LN 39744M 24068M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Bristol Myers Squibb BMY:US $ 37213M 405M
Cerulean Pharma CERU:US $ 31.89M 24.14M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Eli Lilly And LLY:US $ 7757M 1312.6M
Emergent Biosolutions EBS:US $ 1522.7M 21M
Exelixis EXEL:US $ 2112.45M 69.37M
Halozyme Therapeutics HALO:US $ 281.67M 161.93M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Immunogen IMGN:US $ 77.09M 8.63M
Intrexon XON:US $ 131.25M 27.95M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Macrogenics MGNX:US $ 291.44M 27.61M
Nektar Therapeutics NKTR:US $ 801.54M 103.44M
Novartis NVS:US $ 56771M 2729M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Seattle Genetics SGEN:US $ 3164.96M 226.32M